Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05662449
Other study ID # 209339
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date July 1, 2025

Study information

Verified date December 2022
Source NHS Grampian
Contact Mariam Sattar, MBChB(Hons)
Phone 00441224552310
Email mariam.sattar@nhs.scot
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators aim to evaluate the fixation of the ankle syndesmosis in appropriate ankle fractures with bioabsorbable screws. Ankle fractures are common, and a proportion of them involve both fracture of the bone and also disruption of the syndesmosis, a strong ligamentous complex connecting the distal fibula and tibia. If left without fixation this causes a high incidence of pain and early arthritis. The most common technique for fixation of this syndesmosis involves the use of the same type of metal screws used to fix the fractured bones. As the syndesmosis permits small degrees of movement in normal subjects, fixation of this with metal usually leads to screw breakage and, or pain. It is common practice to remove these screws after a period of time once the syndesmosis has healed in the correct position. Bioabsorbable screws have the advantage of allowing small increments of movement, and also resorb naturally therefore do not have to be removed with a second surgical procedure. They are used in other centres worldwide, and the investigators therefore seek to evaluate syndesmosis fixation with them in their unit. The investigators would aim to recruit patients who have a syndesmotic injury requiring fixation, and who can consent to participating. They would undergo an identical surgical procedure to the standard current practice, apart from using a bioabsorbable screw in exchange for the metallic screw for syndesmosis fixation. All other components would remain unchanged, as would post operative protocol and management. To evaluate the fixation the investigators would use a limited CT scan (equivalent of about 3 months background radiation) after the time of fixation and at one year. This will help to assess the maintenance of reduction of the syndesmosis with time. The investigators would also assess patient reported outcome measures and pain scores, length of procedure and intraoperative radiation levels, weight bearing distribution tests, as well as any complication that may arise.


Description:

Surgical Technique The operation requires the patient positioned supine with a sandbag beneath the ipsilateral buttock to internally rotate the leg to permit the ankle and foot to sit in neutral. Appropriate antibiotics as per local guidelines should be administered prior to insufflation of a tourniquet. Fluoroscopy is required throughout the procedure and should be positioned on the contralateral side to the injured limb to improve the access for the surgical team. Depending on the injury type the fibula may or may not require fixation (maissoneuve or weber B/C type injury). This will be performed if necessary via a direct lateral approach to the fibula, and fixation as per surgeon preference appropriate for the fracture configuration. Typically a lag screw and one-third tubular neutralisation plate is used. Plates should be applied to the posterolateral surface of the fibula to permit passage of the syndesmosis screw through the plate and for increased mechanical stability. Following this the syndesmosis will be reduced with the foot plantigrade using large pointed reduction forceps with or without a K-wire. Medial malleolar fixation, if required, is performed after fibula fixation. Bio-absorbable screw fixation A single 4.5 mm fully threaded ActivascrewTM (2094913CE01) is placed through four cortices if the fibula fracture is being fixed, through the plate if feasible. Two are used in the case of high fibula or maissoneuve injuries. These will all be through four cortices. A countersink may be used. The screws should be placed parallel to the tibial plafond, 2-4cm proximal to the tibio-talar joint and 30° from posterior to anterior. In the case of fibula fixation this should be though the plate if feasible. The reduction of the syndesmosis and appropriate placement of the positioning screw(s) should be checked intra-operatively with fluoroscopy. The syndesmosis is reduced, using reduction forceps. A hole is drilled with the 3.5mm drill, then tapped with the 4.5mm tap and measured. The ActivascrewTM holder and screwdriver are used to pick up and insert the desired screw. Once the screw is in position the insertion adapter is removed and discarded. Standardised rehabilitation protocol Post operatively the patient remains non weight-bearing in a Plaster for a total of 6 weeks with a cast change, wound check and removal of sutures at 2 weeks. Following this the patient would then remain partial weight bearing in a protective boot for a further 6 weeks. The patients should be prescribed 6 weeks of Low Molecular Weight Heparin for venous thromboembolic prophylaxis as per local protocol. Sample size considerations A total number of 40 patients should be sufficient to assess the outcome of fixation using this device. Patients selection and enrolment Patients will be thoroughly screened to assess their suitability for the study and must fit the inclusion and exclusion criteria.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date July 1, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - • Patient has a Weber C fibula fracture with or without a medial malleolus fracture and evidence of radiological syndesmotic widening on intra-operative stressing - Patient has a Weber B fracture with evidence of syndesmosis widening radiologically on stressing intra-operatively - Patient has a maissoneuve type injury with evidence of syndesmotic diastasis - Patient mobilises independently, with or without aids. - Patient has given formal consent to be involved in the trial and has completed the study consent form - Patient is likely to comply with study requirements - Patient is over the age of 18 years and under 65 years Exclusion Criteria: - • Immobility - Presence of a posterior malleolus fracture involving >25% of articular surface - Open fractures - Pathological fractures - Other fractures involving the same lower extremity - Patient unwilling to give informed consent to be included in the trial - Patient has other injuries that would influence the study - Any ankle fracture that the treating surgeon feels inappropriate to be included in the study

Study Design


Intervention

Device:
Syndesmosis fixation using Activascrew
as described prior

Locations

Country Name City State
United Kingdom Aberdeen Royal Infirmary Aberdeen

Sponsors (1)

Lead Sponsor Collaborator
NHS Grampian

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Phisitkul P, Ebinger T, Goetz J, Vaseenon T, Marsh JL. Forceps reduction of the syndesmosis in rotational ankle fractures: a cadaveric study. J Bone Joint Surg Am. 2012 Dec 19;94(24):2256-61. doi: 10.2106/JBJS.K.01726. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Computerised Tomography (CT) scan syndesmosis All patients will undergo focused CT scanning two weeks post operatively and at one year. A customised foot holding device will enable to scan to be taken with both feet in neutral alignment (Evolution supine foot positioner, Vasocare Ltd). Assessment will be made in comparison with the contralateral side to assess reduction of the syndesmosis. Quantitive measurement of reduction will be measured using an established technique from the paper cited below in references. Change in reduction between 2 weeks and 1 year post operatively
Secondary Surgical Duration Tourniquet time (minutes) to represent this Intraoperative
Secondary X- Ray (XR) Radiation exposure time and total dose Image intensifier screening total time(seconds) and dose(cGycm2) Intraoperative
Secondary Olerud-Molander Ankle Score (OMAS) (Olerud-Molander Ankle Scores). Verified and reproducible patient reported scale for ankle function and symptoms. Range 0-100. High score is better. Pre-operative (baseline), 3 months, 6 months and 1 year post operatively. Absolute values measured as well as change in score over time intervals noted.
Secondary EQ5D3L (European Quality of Life 5 Dimensions 3 Level Version) EQ-5D-3L (European Quality of Life 5 Dimensions 3 Level Version). Validated patient health questionnaire. Score range 5-15. Lower score is better. Pre-operative (baseline), 3 months, 6 months and 1 year post operatively.Absolute values measured as well as change in score over time intervals noted.
Secondary EQ-5D-3L VAS (European Quality of Life 5 Dimensions 3 Level Version) Health state Validated patient health questionnaire. Score range 0-100. High score is better. Pre-operative (baseline), 3 months, 6 months and 1 year post operatively.Absolute values measured as well as change in score over time intervals noted.
Secondary American Academy Orthopaedic Surgeons Foot and Ankle Outcomes (AAOSFA) Verified and reproducible patient reported scale for Pain, Function, Shoe wear and Alignment (numerical scoring system). Range 0-100. High score is better. Pre-operative (baseline), 3 months, 6 months and 1 year post operatively.Absolute values measured as well as change in score over time intervals noted.
Secondary Complications Details of any recorded minor and major complications Up to 12 months
Secondary X-Rays (XR) Mortise and lateral XR to assess alignment if satisfactory 2 weeks, 6 weeks, 3 months, 6 months and 1 year post operatively.
Secondary Weight bearing tests Assessment if can weight bearing. Stand on two sets of scales, one foot on each scale. Timed over 1 minute and assess how much weight (kg) is on each scale at 15 second intervals. 3 months, 6 months and 1 year post operatively
See also
  Status Clinical Trial Phase
Recruiting NCT05555459 - Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation N/A
Completed NCT04235907 - Telerehabilitation Following Ankle Fractures N/A
Completed NCT02949674 - Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients Phase 3
Completed NCT02198768 - Ankle Fracture vs Ankle Fracture-Dislocation
Recruiting NCT05916300 - Diagnostic Ultrasonography in Physiotherapy
Recruiting NCT04674046 - Deep Deltoid Ligament Integrity in Weber B Ankle Fractures - Mini-invasive Arthroscopic Evaluation. N/A
Recruiting NCT03696199 - Randomized Controlled Trial for Ankle Fracture Pain Control Phase 4
Recruiting NCT03259204 - Swedish Multicenter Trial of Outpatient Prevention of Leg Clots N/A
Not yet recruiting NCT03625154 - Operative Versus Non Operative Management Outcomes of Isolated Lateral Malleolar Weber B Ankle Fractures N/A
Active, not recruiting NCT03769909 - Prevention of Posttraumatic Osteoarthritis After Acute Intraarticular Fractures
Recruiting NCT05280639 - Simplified Post Op Rehabilitation for Ankle and Pilon Fractures N/A
Completed NCT02967172 - Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures Phase 4
Withdrawn NCT04768478 - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF Phase 4
Completed NCT05084794 - The Results of Middle-sized Posterior Malleolus Fractures: Fixed Versus Non-fixed N/A
Completed NCT03741556 - Prognostic Factors Following Ankle Fractures
Active, not recruiting NCT02481076 - Compression in Anklefracture Treatment, The CAT-study N/A
Recruiting NCT05729542 - Comparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries N/A
Not yet recruiting NCT06086223 - Functional Outcomes Following Ankle Fracture Fixation With or Without Ankle Arthroscopy N/A
Recruiting NCT05389436 - Outpatient Versus Inpatient Surgery for Ankle Fractures N/A
Not yet recruiting NCT06329752 - Sciatic Nerve Block for Ankle and Leg Fracture Manipulation in the Emergency Department N/A